Company Search:
Advanced Search
Sponsored Links
Viromed Company Ltd Company Snapshot
Viromed Company Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Viromed Company Ltd with three other companies in this sector in South Korea: ISU Abxis Company Limited (2015 sales of 11.47 billion Korean Won [US$10.15 million] of which 100% was Antibody Medicine), Alteogen Inc (4.73 billion Korean Won [US$4.18 million] ), and Tego Science Inc (7.49 billion Korean Won [US$6.63 million] ).

Sales Analysis. During the year ended December of 2015, sales at Viromed Company Ltd were 7.70 billion Korean Won (US$6.81 million). This is an increase of 25.4% versus 2014, when the company's sales were 6.14 billion Korean Won. This was the fourth straight year of sales growth at Viromed Company Ltd.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Viromed Company Ltd
  Stock Performance Chart for Viromed Company Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 97,300
(Figures in Korean Won)
1 Week 0.3%   13 Weeks -21.7%  
4 Weeks -20.1%   52 Weeks -28.3%  
Viromed Company Ltd Key Data:
  Ticker: 084990 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 7,695,186,310
(Year Ending Jan 2016).
Employees: 59
  Currency: Korean Won Market Cap: 1,422,268,345,855
  Fiscal Yr Ends: December Shares Outstanding: 14,662,560
  Share Type: Common Closely Held Shares: 2,249,761
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.